Bet On This Biotech Before Earnings

 | Nov 08, 2019 01:06AM ET

Biopharmaceutical name Amicus Therapeutics Inc (NASDAQ:FOLD} is expected to disclose its third-quarter earnings report before the open next Monday, Nov. 11. The stock is inching higher ahead of the event, up 1.3%, at last check. What's more, a long-term sign of technical support has just emerged, too, by way of FOLD stock's 80-month moving average.